The Cost-Effectiveness of Starting 23-Valent Pneumococcal Polysaccharide Vaccine and Influenza Vaccination at 50 Vs. 65 Years: A Comparative Modelling Study
Vaccine（2022）
关键词
Pneumococcal infection,Vaccine,Quality-adjusted life-years,Cost-effective analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要